Tyra Biosciences, Inc.TYRANASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-4.74%
↑ 71% above average
Average (22q)
-16.11%
Historical baseline
Range
High:12.92%
Low:-57.68%
Volatility
-438.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -4.74% |
| Q2 2025 | 1.25% |
| Q1 2025 | -7.08% |
| Q4 2024 | -3.99% |
| Q3 2024 | -21.55% |
| Q2 2024 | -5.42% |
| Q1 2024 | 12.92% |
| Q4 2023 | -6.97% |
| Q3 2023 | -49.64% |
| Q2 2023 | -11.72% |
| Q1 2023 | 4.55% |
| Q4 2022 | -10.06% |
| Q3 2022 | 11.56% |
| Q2 2022 | -4.00% |
| Q1 2022 | -49.36% |
| Q4 2021 | -49.62% |
| Q3 2021 | -20.52% |
| Q2 2021 | -30.80% |
| Q1 2021 | -14.52% |
| Q4 2020 | -57.68% |
| Q3 2020 | -27.29% |
| Q2 2020 | -25.82% |
| Q1 2020 | 0.00% |